Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zarzenda versus Elidel in children and adolescents with mild to moderate atopic dermatitis
2007-002133-36Phase 4Completed
- Sponsor
- Intendis
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ethinyl estradiol + drospirenone and pimecrolimus in atopic dermatitis (AD) (2 arms), sponsored by Intendis. Primary endpoint: Investigator's Global Assessment success/failure. Started Aug 2007; status: completed.
02
Drugs
ethinyl estradiol + drospirenonepimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-002133-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002133-36.